Lantheus Holdings, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.
The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.
“Our lead molecule, LMI 1174, has been used to demonstrate utility in a number of different animal models.” (Page 121) Read the following document
Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of innovative diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The company products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. It operates through the following segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sell its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 2007 and is headquartered in North Billerica, MA. [Source: MarketWatch]
Company Website: http://www.lantheus.com